S&P revised its outlook to 'positive' from 'stable' as the stake sale in its lifescience unit will strengthen its financials
from BloombergQuint https://ift.tt/NCZMVSL
from BloombergQuint https://ift.tt/NCZMVSL
Glenmark Pharma Shares Surge 10% On S&P Rating Outlook Upgrade
Reviewed by aamira sultan
on
September 29, 2023
Rating:
No comments: